Prevalence of molecular markers of anti-malarial drug resistance in Plasmodium vivax and Plasmodium falciparum in two districts of Nepal

BACKGROUND: Sulphadoxine-pyrimethamine (SP) and chloroquine (CQ) have been used in treatment of falciparum and vivax malaria in Nepal. Recently, resistance to both drugs have necessitated a change towards artemisinin combination therapy (ACT) against Plasmodium falciparum in highly endemic areas. Ho...

Descripción completa

Detalles Bibliográficos
Autores principales: Ranjitkar, Samir, Schousboe, Mette L, Thomsen, Thomas Thyge, Adhikari, Madhav, Kapel, Christian MO, Bygbjerg, Ib C, Alifrangis, Michael
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3080351/
https://www.ncbi.nlm.nih.gov/pubmed/21457533
http://dx.doi.org/10.1186/1475-2875-10-75

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3080351/
https://www.ncbi.nlm.nih.gov/pubmed/21457533
http://dx.doi.org/10.1186/1475-2875-10-75

Ejemplares similares